Optiscan Signs Know-How Agreement with Mayo Clinic
Optiscan Imaging Limited (ASX:OIL) (‘Optiscan’ or ‘The Company’) is pleased to announce that it has entered into a collaboration through a know-how agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for use in robotic surgery.
The collaboration combines Optiscan’s engineering expertise in digital endomicroscopic hardware and software development with Mayo Clinic’s know-how in robotic surgery and quality patient care. The agreement, which covers a 24-month co-development plan, will bring together experts from both companies to develop a robot-compatible endomicroscopic imaging system with an initial focus on robotic-assisted breast cancer surgery.
Optiscan CEO and Managing Director, Dr Camile Farah, said: “We’re excited to collaborate with Mayo Clinic to accelerate the development and clinical testing of our robotic imaging platform with the aim of fast-tracking the adoption of real-time digital pathology and image-guided precision robotic surgery. This collaboration is built on a shared history of innovation and a laser focus on delivering the highest quality patient outcomes for better health care delivery.”
Mayo Clinic is the largest integrated, not-for-profit medical group practice in the world, focussed on transforming health care and building a healthier world. Its drive to deliver better medical care has earned it more top rankings for high-quality patient care than any other health care organization. It has more #1 rankings than any other hospital in the US, and is top-ranked in more specialties than any other US hospital. The hospital undertakes more than 141,000 surgical cases and performs more than 4,000 robotic surgery cases a year.
The robotic-assisted surgery market is experiencing significant growth and is expected to continue expanding driven by technological advancements, increasing adoption, rising prevalence of chronic diseases, an aging population, surgeon demand, and favourable reimbursement policies. The US robotic surgery service market was valued at $1.8 Bn in 2022 and is estimated to grow at a compound annual growth rate (CAGR) of 17.3% to reach $6.4 Bn in 2030.
Dr Farah adds: “The collaboration is part of Optiscan’s wider strategic focus on the US market, and its plan to embed its platform technology as a key component of intraoperative oncological surgery workflows in a variety of settings and clinical applications to provide surgeons with real-time microscopic information of cancer clearance for the potential to reduce missed cancers and minimise repeat surgeries due to residual disease.”
Mayo Clinic has a financial interest in the technology referenced in this announcement. Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education and research.
This announcement has been authorised for release by the Board of Optiscan.
About Optiscan
Optiscan Imaging Ltd (ASX:OIL) is a global leader in the development, manufacturing, and commercialisation of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. Our technology enables real-time, non-destructive, 3D, in-vivo digital imaging at the single-cell level.
We are driven by developing technology and its use to give healthcare providers and researchers the highest quality real-time microscopic imaging tools to enable the early detection and management of disease, improve patient outcomes, and reduce the high cost of curative medicine and associated procedures.
Our patent-protected proprietary technology, using specially miniaturised componentry, has created a pen-sized digital microscope, which can be used on any tissue it contacts to produce high resolution digital pathology images for cancer diagnosis and surgical margin detection in real-time. The aim of our technology development is for earlier diagnosis and subsequent treatment of cancerous tumours with expected associated improved patient outcomes.
To learn more about Optiscan, visit www.optiscan.com or follow us on LinkedIn, X or Instagram.
To learn more about Mayo Clinic, visit www.mayoclinic.org
Disclaimer
All statements other than statements of historical fact included on this announcement including, without limitation, statements regarding future plans and objectives of Optiscan or any of the other parties referred to herein, are forward-looking statements. Forward-looking statements can be identified by words such as ‘anticipate”, “believe”, “could”, “estimate”, “expect”, “future”, “intend”, “may”, “opportunity”, “plan”, “potential”, “project”, “seek”, “will” and other similar words that involve risks and uncertainties. These statements are based on an assessment of present economic and operating conditions, and on assumptions regarding future events and actions that are expected to take place. Such forward-looking statements are not guarantees of future performance and involve known and unknown risks, uncertainties, assumptions and other important factors, many of which are beyond the control of the Company, its directors and management of Optiscan that could cause actual results to differ from the results expressed or anticipated in these statements.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240513411030/en/
Contact information
For further information:
Shareholder & General Enquiries
Optiscan Imaging Ltd
Dr Camile Farah
M: +61 3 9538 3333
E: ceo@optiscan.com
Media & Investor Enquiries
The Capital Network
Russell Katz
M: +61 2 8999 3699
E: russell@thecapitalnetwork.com.au
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Everyone Talks CX. Almost No One Delivers.7.7.2025 11:51:00 EEST | Press release
Global cloud communications platform Infobip has today released findings from a new study conducted by Harvard Business Review Analytic Services (HBR-AS) revealing a sharp disconnect in customer experience (CX): while 93% of those surveyed from the HBR audience recognize the high importance of creating positive conversational experiences, only 36% believe their organization is highly effective at it. Even more striking, just 11% report they’re highly effective using AI to deliver human-like conversations. The untapped potential of AI in customer engagement The report, “Conversational Experiences: The Untapped Potential of AI in Customer Engagement” highlights a gap between organizations’ ambitions and execution: while many use SMS, messaging apps, email and chatbots at key points, most still fail to deliver the seamless, intuitive conversations customers expect. “While everyone talks CX, almost no one delivers,” said Ben Lewis, VP Marketing and Growth at Infobip. “When brands can’t del
Geneva Business School Celebrates 30 Years of International Excellence at Its Graduation Ceremony in Barcelona7.7.2025 11:29:00 EEST | Press release
Geneva Business School held its traditional graduation ceremony this week in Barcelona, marked this year by a very special occasion: the institution’s 30th anniversary. With more than three decades of experience shaping business leaders in a globalized environment, Geneva Business School has consolidated its practical and international teaching model, inspired by Swiss academic standards, as a key reference in the Spanish educational ecosystem. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250704769866/en/ “Our students are entering a world marked by complex geopolitical challenges, a world in urgent need of a new style of leadership. Their education at Geneva Business School has instilled in them a deep understanding of what it means to lead with integrity on a global stage,” said Mrs. Nicola Jackman, Global Head of Academics at Geneva Business School, during her speech at the ceremony. With campuses in Barcelona and Madri
IBA President Umar Kremlev Joins Terence Crawford and Tyson Fury to Usher in Golden Era of International Boxing Association7.7.2025 10:00:00 EEST | Press release
Some of boxing’s biggest names gathered in Istanbul as International Boxing Association (IBA) President Umar Kremlev unveiled plans for the sport’s “Golden Era.” Joined by pound-for-pound star Terence Crawford and heavyweight icon Tyson Fury, Kremlev outlined IBA’s vision to build an ecosystem supporting fighters at every level- amateur, professional, and bare-knuckle. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707636910/en/ IBA Press Conference (Photo: AETOSWire) “I’m thrilled to welcome so many champions to this event for the development of boxing,” said Kremlev. “Our goal is to ensure every athlete knows IBA is their home. Wherever a boxer is, IBA will support them. It’s our duty to create opportunities for children to build better futures for themselves and their families.” Kremlev stressed boxing’s roots: “We’re creating an ecosystem covering amateur, professional, and bare-knuckle boxing. Why bare-knuckle? That’
Nrep and Slate Asset Management Enter Agreement on Essential Real Estate Portfolio in Denmark7.7.2025 09:00:00 EEST | Press release
Urban Partners’ real estate arm, Nrep, together with StepStone Real Estate (“SRE”), the real estate arm of private markets investment firm StepStone Group (Nasdaq: STEP), are pleased to announce the sale of a portfolio of five grocery-anchored retail properties and two adjacent residential properties in Greater Copenhagen. The portfolio is being acquired by a joint venture between Slate Asset Management (“Slate” or the “Firm”), a global investor and manager focused on essential real estate and infrastructure assets, and OneIM, a global alternative investment manager that invests across the capital structure in a range of asset classes. OneIM is Slate’s capital partner in the transaction, which is the first for Slate and OneIM’s joint venture. The joint venture is actively targeting further acquisitions across the European essential retail sector. The acquisition marks Slate’s first investment in Denmark and further increases the Firm’s portfolio of high-quality essential real estate as
SCENTMATIC's AI "KAORIUM" Debuts at THAMEEN Fragrance Launch in London's Selfridges4.7.2025 12:13:00 EEST | Press release
SCENTMATIC Inc., a leader in scent digitalization, introduced its AI-powered scent-to-language system, KAORIUM, at the THAMEEN Fragrance new product launch event. This pivotal event took place from June 5 to 11, 2025, at Selfridges department store in London, UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703662207/en/ State of exhibition Global Expansion: KAORIUM Establishes UK Presence Europe leads the global fragrance market, with the UK projected to reach US$2.82 billion by 2033. Recognizing this, SCENTMATIC is rapidly expanding its international footprint. In May 2024, SCENTMATIC established its overseas subsidiary, KAORIUM, in London, appointing industry expert Ben Yanoushek as CEO. Official UK operations commenced on February 1, 2025, with the launch of its dedicated website: www.kaorium.com. KAORIUM Trialed at "Florentine Diamond" Launch Event The "Florentine Diamond" launch event for luxury brand THAMEEN Frag
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom